Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05149664 · ClinicalTrials.gov registry record · NA

A Non-significant Risk Clinical Study: Changes in Perfusion After Therapeutic Ultrasound in Patients With PAD

A NA study of Peripheral Arterial Disease (PAD), sponsored by Vibrato Medical.

Active
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT05149664 is a NA study of Peripheral Arterial Disease (PAD) that is active but no longer recruiting, run by Vibrato Medical. The registered enrollment target is 12 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05149664, a NA study of Peripheral Arterial Disease (PAD), is active but no longer recruiting, sponsored by Vibrato Medical.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

All evaluable subjects will receive VibratoSleeve therapeutic ultrasound (TUS) treatments. The device will be programmed to deliver TUS at a pre-determined level. Three different acoustic intensity levels will be tested during the first three treatment visits (one at each visit day). The most effective treatment that is comfortable to a subject will be prescribed for the remaining treatment sessions. Treatment time will be 90 minutes per session, one session per day. Thirty treatment sessions will be performed over a 45-day period. Subjects will appear for on-site follow-up visits at 1-, 3-, and 6-months following subject's last (30th) treatment session.

Interventions

  • DEVICE Therapeutic ultrasound (TUS)

Study Locations (1)

California

  • Vascular & Interventional Specialists of Orange County - Orange

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2022-01-14
Est. Completion 2023-12
Phase NA

Sponsor

Vibrato Medical

4 total trials

What the Registry Record Tells You About NCT05149664

The ClinicalTrials.gov registry entry for NCT05149664 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vibrato Medical, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Peripheral Arterial Disease (PAD) appearing as the primary indexed condition, and to 1 intervention - of which Therapeutic ultrasound (TUS) is the first listed.

NCT05149664 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05149664 about?

NCT05149664 is a clinical study titled "A Non-significant Risk Clinical Study: Changes in Perfusion After Therapeutic Ultrasound in Patients With PAD". All evaluable subjects will receive VibratoSleeve therapeutic ultrasound (TUS) treatments. The device will be programmed to deliver TUS at a pre-determined level. Three different acoustic intensity levels will be tested during the first three treatment visits (one at each visit day). The most effect...

What is the current status of trial NCT05149664?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2022-01-14. Estimated completion is 2023-12.

What conditions does trial NCT05149664 study?

This clinical trial studies the following conditions: Peripheral Arterial Disease (PAD).

What interventions are being tested in trial NCT05149664?

The interventions under investigation include: Therapeutic ultrasound (TUS) (DEVICE).

Who is sponsoring clinical trial NCT05149664?

This trial is sponsored by Vibrato Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05149664 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Peripheral Arterial Disease (PAD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.